These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38058449)

  • 1. Both recombinant
    Zhang Y; Wu Y; Peng C; Li Z; Wang G; Wang H; Yu L; Wang F
    Heliyon; 2023 Dec; 9(12):e22941. PubMed ID: 38058449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
    Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
    Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response in piglets orally immunized with recombinant Bacillus subtilis expressing the capsid protein of porcine circovirus type 2.
    Zhang S; Mou C; Cao Y; Zhang E; Yang Q
    Cell Commun Signal; 2020 Feb; 18(1):23. PubMed ID: 32046726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells.
    Wang Y; Xu F; Yuan C; Zhang Y; Ren J; Yue H; Ma T; Song Q
    Vaccine; 2024 Apr; 42(11):2848-2857. PubMed ID: 38514351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
    Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
    Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A porcine circovirus type 2d-based virus-like particle vaccine induces humoral and cellular immune responses and effectively protects pigs against PCV2d challenge.
    Kim K; Choi K; Shin M; Hahn TW
    Front Microbiol; 2023; 14():1334968. PubMed ID: 38274769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The truncated form of flagellin (tFlic) provides the 2dCap subunit vaccine with better immunogenicity and protective effects in mice.
    Lu Y; Liu Z; Li Y; Deng Z; Fang W; He F
    Anim Dis; 2022; 2(1):11. PubMed ID: 35669451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
    Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a virus-like particles induces a protective immune response against porcine circovirus type 2 in mice.
    Li YA; Sun Y; Zhang Y; Wang S; Shi H
    Vaccine; 2022 Aug; 40(33):4732-4741. PubMed ID: 35773121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live-Attenuated
    Lloren KKS; Lee JH
    Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface Display of
    Li W; Li J; Dai X; Liu M; Khalique A; Wang Z; Zeng Y; Zhang D; Ni X; Zeng D; Jing B; Pan K
    Front Immunol; 2022; 13():1007202. PubMed ID: 36189301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2d.
    Kim K; Hahn TW
    Vaccine; 2021 Jan; 39(3):529-535. PubMed ID: 33342633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
    Jung BK; Kim HR; Lee YH; Jang H; Chang KS
    J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.
    Liu X; Liu Y; Zhang Y; Zhang F; Du E
    BMC Vet Res; 2020 Feb; 16(1):45. PubMed ID: 32028949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity Analysis of PCV3 Recombinant Capsid Protein Virus-like Particles and Their Application in Antibodies Detection.
    Cao X; Huang M; Wang Y; Chen Y; Yang H; Quan F
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles.
    Liu ZH; Deng ZF; Lu Y; Fang WH; He F
    J Nanobiotechnology; 2022 Nov; 20(1):493. PubMed ID: 36424615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
    Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ
    Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.
    Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T
    J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Delivery of Nanovaccine to Dendritic Cells via DC-Binding Peptides Induces Potent Antiviral Immunity in vivo.
    Lu Y; Liu ZH; Li YX; Xu HL; Fang WH; He F
    Int J Nanomedicine; 2022; 17():1593-1608. PubMed ID: 35411142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
    Wu PC; Chen TY; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.